New and promising GSM treatments, more clinical takeaways from NAMS 2018

Dr. Richard-Davis served as the Scientific Program Chair of the 2018 North American Menopause Society (NAMS) Meeting. In this audiocast she highlights several clinical takeaways from the meeting, including:

• new treatments for uterine fibroids
• the telomere’s role in helping women live longer lives, and protective (estrogen) and adverse (stress, obesity) factors affecting telomere length that patients can address through a healthy lifestyle
• the legal risks of not screening for hereditary cancer
• obesity prevention, treatment, and long-term lifestyle changes during menopause
• new and on-the-horizon therapies for GSM
• much more.